Festphasensynthese eines tumorassoziierten Sialyl-TN-Antigen-Glycopeptids mit einer Partialsequenz aus dem Tandem-Repeat des MUC-1-Mucins

1997 ◽  
Vol 109 (6) ◽  
pp. 629-631 ◽  
Author(s):  
Beate Liebe ◽  
Horst Kunz
Cancer ◽  
1993 ◽  
Vol 72 (6) ◽  
pp. 1836-1840 ◽  
Author(s):  
Ikuo Takahashi ◽  
Yoshihiko Maehara ◽  
Tetsuya Kusumoto ◽  
Motofumi Yoshida ◽  
Yoshihiro Kakeji ◽  
...  

2016 ◽  
Vol 28 (2) ◽  
pp. 140
Author(s):  
G. A. Kim ◽  
J.-X. Jin ◽  
S. Lee ◽  
A. Oh ◽  
B. C. Lee

It is considered that GGTA1 knockout (KO) pig production via somatic cell NT would overcome the problem of immune rejection after xenotransplantation. It is reported that although GGTA KO mice showed only a mild increase in sialyltransferase gene expression, GGTA1 deficiency in pig could increase the sialyltransferase activities, non-Gal epitope expression, consequently may raise non-Gal xenoantigenicity. Therefore, in the present study we investigated whether the expression level of Sia-containing glycoconjugate mRNA in transgenic pigs could be affected by knocking out the GGTA1 gene. Besides GGTA1 KO pigs, double genes overexpressing pigs (2TG) and GGTA1 KO with double genes overexpressing (KO+2TG) pigs were produced by somatic cell NT. For the present study, fibroblasts were isolated from wild-type pigs without gene modification, 2TG, GGTA1 KO, and KO+2TG pig. The GAPDH gene was used as an internal standard to normalise the real-time PCR (RT-qPCR) analysis reaction efficiency and to quantify mRNA in pigs-derived fibroblast. The expression levels were compared between them (RT-qPCR) in triplicate for each sample. Oligonucleotide primers for real-time PCR were designed for Hanganutziu-Deicher antigen (ST3Gal1–4, ST6Gal1) and Sialyl-Tn antigen (ST6GalNac1, ST6GalNac2, and ST6GalNac6) analysis. For statistical analysis, one-way ANOVA with Dunn’s multiple comparison test were used. The mRNA expression of GGTA1 KO and KO+2TG pig derived fibroblasts cells genes showed that ST3Gal1, ST3Gal2, ST3Gal3, and ST6Gal1 gene expression were significantly up-regulated compared to the wild and 2TG pigs (P < 0.05). However, ST3Gal4, Sialyl-Tn antigen including ST6GalNac1, ST6GalNac2, and ST6GalNac6 in KO+2TG pigs were not different compared with the wild pigs (P > 0.05), whereas only GGTA1 KO pigs showed significantly higher expressions than wild, 2TG, and KO+2TG pigs (P < 0.05). These results demonstrated that GGTA KO pig-derived cells exhibit a higher Hanganutziu-Deicher antigen on glycoprotein and glycolipid than controls, and KO+2TG pig exhibit no differences when compared with GGTA1 KO pig, indicating that they do not act as an immune antigen in xenograft. Overall, the increase in glycosyltransferase expression suggests a corresponding increase in the cell surface sialyation in GGTA KO pig cells. For xenotransplantation, KO+2TG pigs were more preferable because of absence of immune rejection for Sia-containing glycoconjugate on glycoprotein and glycolipid than GGTA KO pigs. This study was supported by the Ministry of Trade, Industry and Energy (#10048948), Korea IPET (#114059–3), Research Institute for Veterinary Science, TS Corporation, and the BK21 plus program.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Yayoi Yoshimura ◽  
Kaori Denda-Nagai ◽  
Yoshie Takahashi ◽  
Izuru Nagashima ◽  
Hiroki Shimizu ◽  
...  

Abstract Anti-mucin1 (MUC1) antibodies have long been used clinically in cancer diagnosis and therapy and specific bindings of some of them are known to be dependent on the differential glycosylation of MUC1. However, a systematic comparison of the binding specificities of anti-MUC1 antibodies was not previously conducted. Here, a total of 20 glycopeptides including the tandem repeat unit of MUC1, APPAHGVTSAPDTRPAPGSTAPPAHGV with GalNAc (Tn-antigen), Galβ1-3GalNAc (T-antigen), NeuAcα2-3Galβ1-3GalNAc (sialyl-T-antigen), or NeuAcα2-6GalNAc (sialyl-Tn-antigen) at each threonine or serine residue were prepared by a combination of chemical glycopeptide synthesis and enzymatic extension of carbohydrate chains. These glycopeptides were tested by the enzyme-linked immunosorbent assay (ELISA) for their capacity to bind 13 monoclonal antibodies (mAbs) known to be specific for MUC1. The results indicated that anti-MUC1 mAbs have diverse specificities but can be classified into a few characteristic groups based on their binding pattern toward glycopeptides in some cases having a specific glycan at unique glycosylation sites. Because the clinical significance of some of these antibodies was already established, the structural features identified by these antibodies as revealed in the present study should provide useful information relevant to their further clinical use and the biological understanding of MUC1.


2012 ◽  
Vol 22 (4) ◽  
pp. 531-538 ◽  
Author(s):  
Kaoru Akita ◽  
Shuhei Yoshida ◽  
Yuzuru Ikehara ◽  
Sayumi Shirakawa ◽  
Munetoyo Toda ◽  
...  

1995 ◽  
Vol 21 (4) ◽  
pp. 385-389 ◽  
Author(s):  
Fumitaka Numa ◽  
Nagato Tsunaga ◽  
Toru Michioka ◽  
Shugo Nawata ◽  
Hidenobu Ogata ◽  
...  

1999 ◽  
Vol 6 (4) ◽  
pp. 391-395 ◽  
Author(s):  
Atsushi Nanashima ◽  
Hiroyuki Yamaguchi ◽  
Tohru Nakagoe ◽  
Seiji Matsuo ◽  
Yorihisa Sumida ◽  
...  

Glycobiology ◽  
2012 ◽  
Vol 23 (2) ◽  
pp. 178-187 ◽  
Author(s):  
R. Takamiya ◽  
K. Ohtsubo ◽  
S. Takamatsu ◽  
N. Taniguchi ◽  
T. Angata

Sign in / Sign up

Export Citation Format

Share Document